|
PLOD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62492241884138E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.16549997325666E-09 |
| Normal-vs-Stage2 |
5.846500E-04 |
| Normal-vs-Stage3 |
3.077800E-03 |
| Normal-vs-Stage4 |
2.379600E-03 |
| Stage1-vs-Stage2 |
4.478400E-01 |
| Stage1-vs-Stage3 |
9.288400E-02 |
| Stage1-vs-Stage4 |
1.279170E-01 |
| Stage2-vs-Stage3 |
2.310600E-01 |
| Stage2-vs-Stage4 |
3.584200E-01 |
| Stage3-vs-Stage4 |
6.168200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.19313456284453E-12 |
| Normal-vs-AfricanAmerican |
5.34009999997309E-07 |
| Normal-vs-Asian |
2.787800E-01 |
| Caucasian-vs-AfricanAmerican |
9.014200E-01 |
| Caucasian-vs-Asian |
3.823000E-01 |
| AfricanAmerican-vs-Asian |
3.217600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.62105917367717E-13 |
| Normal-vs-Female |
8.23529999749439E-08 |
| Male-vs-Female |
8.319400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.94431999999134E-05 |
| Normal-vs-Extreme_Weight |
1.14650000049288E-07 |
| Normal-vs-Obese |
6.09849999999579E-05 |
| Normal-vs-Extreme_Obese |
5.521900E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.202400E-01 |
| Normal_Weight-vs-Obese |
5.135600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.652800E-01 |
| Extreme_Weight-vs-Obese |
6.803200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.705600E-01 |
| Obese-vs-Extreme_Obese |
8.691200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.662100E-02 |
| Normal-vs-Age(41-60Yrs) |
2.02060590481778E-14 |
| Normal-vs-Age(61-80Yrs) |
8.36580005270093E-09 |
| Normal-vs-Age(81-100Yrs) |
3.583900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.177600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.184600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.848220E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.621550E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.662590E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.244600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63757896132211E-12 |
| Normal-VS-Type2 PRCC |
3.001600E-04 |
| Normal-VS-KIRP CIMP |
2.638400E-02 |
| Normal-VS-Unclassified PRCC |
2.56379999996614E-06 |
| Type1 PRCC-VS-Type2 PRCC |
1.114830E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.225800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.535600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.561700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.507000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.620100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.54085999999332E-05 |
| Normal-vs-N1 |
7.642000E-03 |
| Normal-vs-N2 |
1.057200E-01 |
| N0-vs-N1 |
1.333580E-01 |
| N0-vs-N2 |
4.232200E-01 |
| N1-vs-N2 |
7.412600E-01 |
|
|
